Challenges in the management of infections due to carbapenem-resistant Enterobacteriaceae

Dimitri M. Drekonja, Susan E. Beekmann, Sean Elliott, Deepa Mukundan, Hari Polenakovik, Marnie E. Rosenthal, Pranita D. Tamma, Philip M. Polgreen, Scott J. Weissman

Research output: Contribution to journalArticle

Abstract

Carbapenem-resistant Enterobacteriaceae (CRE) infections are increasing and are associated with considerable morbidity and mortality. Members of the Emerging Infections Network treating CRE encountered difficulties in obtaining laboratory results and struggled with limited treatment options. In addition, many treated patients experienced an alarming degree of drug toxicity from CRE therapies.

Original languageEnglish (US)
Pages (from-to)437-439
Number of pages3
JournalInfection control and hospital epidemiology
Volume35
Issue number4
DOIs
StatePublished - Jan 1 2014

ASJC Scopus subject areas

  • Epidemiology
  • Microbiology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Challenges in the management of infections due to carbapenem-resistant Enterobacteriaceae'. Together they form a unique fingerprint.

  • Cite this

    Drekonja, D. M., Beekmann, S. E., Elliott, S., Mukundan, D., Polenakovik, H., Rosenthal, M. E., Tamma, P. D., Polgreen, P. M., & Weissman, S. J. (2014). Challenges in the management of infections due to carbapenem-resistant Enterobacteriaceae. Infection control and hospital epidemiology, 35(4), 437-439. https://doi.org/10.1086/675604